Related Experiment Videos
[Calcitonin as medication in pain?]
O Spigset1, T Mjörndal, E Vinge
1Avdelningen för klinisk farmakologi, Norrlands Universitetssjukhus, Umeå.
Nordisk Medicin
|January 1, 1993
Summary
Calcitonin effectively relieves short-term skeletal pain compared to placebo. However, evidence for long-term skeletal pain and extraskeletal pain relief, including migraine, remains insufficient, necessitating further research.
Area of Science:
- Pain Management
- Pharmacology
- Clinical Research
Background:
- Calcitonin demonstrates antinociceptive properties in various studies.
- Skeletal pain (e.g., cancer metastases, osteoporotic fractures) and extraskeletal pain (e.g., phantom limb pain, migraine) are significant clinical challenges.
Purpose of the Study:
- To review controlled clinical studies on calcitonin for skeletal and extraskeletal pain.
- To evaluate the efficacy of calcitonin in pain management based on existing evidence.
Main Methods:
- Systematic review of controlled clinical trials.
- Analysis of studies investigating calcitonin for diverse pain conditions.
Main Results:
- Calcitonin shows a well-documented positive effect against placebo for short-term skeletal pain relief.
- Insufficient evidence exists for long-term skeletal pain and extraskeletal pain treatment efficacy.
- No controlled trials comparing calcitonin to conventional analgesics have been published.
Conclusions:
- Calcitonin is effective for short-term skeletal pain management.
- Further research is required to establish calcitonin's role in long-term pain therapy and extraskeletal pain conditions.
- Comparative studies against standard analgesics are needed to define calcitonin's place in pain management.